Support Pathway for ENT Cancer Patients in a Support Care Day Hospital
Recruiting · NCT06512662 · Interventional (participants receive a specific treatment) · Lead sponsor: Clinique Pasteur Lanroze
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term. Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract. Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.
Who can take part
Inclusion criteria
- patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation
- Understanding of spoken and written French
- Patient covered by a social security scheme
Exclusion criteria
- Protected patient under a protective measure or legal safeguard
- Pregnant or breast-feeding patients
- Patients suffering from major cognitive disorders
- Patients with major anxiety disorders prior to the onset of cancer
Where it is running
1 location listed.
- Clinique Pasteur Lanroze - Brest, France